skip to content

Investors

Roche’s Virtual Hematology Investor Event

Roche has hosted a virtual event on Monday, 23 June 2025

Register to the webcast replay
Presentation download

A gloved hand in a lab coat holds a small, clear vial against a blurred background of lab equipment, conveying a scientific and clinical setting.

Roche Half-Year Results 2025 Presentation

Thursday, 24 July 2025 at 14:00 CEST

More details

A blue-gloved hand delicately holds a small pink container with a QR code. Nearby are green, blue, and yellow containers on a white surface, indicating a scientific setting.

24 million

patients were treated with Roche medicines in 2024

30 billion

Roche Diagnostics test were delivered to customers worldwide in 2024

+1%

Core investments in research and development in 2024: CHF 13.2 billion

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Upcoming Investor events

View all events

Roche Half Year Results 2025 (virtual event)Investors

July 24, 2025 at 14:00 CEST | Basel, Switzerland

UBS Precision Medicine Frontiers SummitInvestors

August 14, 2025 at 10:00 PDT | Dana Point, US

22nd Annual Goldman Sachs European Medtech and Healthcare Services ConferenceInvestors

September 04, 2025 at 08:00 BST | London, UK

Morgan Stanley 23rd Annual Global Healthcare ConferenceInvestors

September 09, 2025 at 08:30 EST | New York, US

Nephron Napa Summit 2025Investors

September 17, 2025 at 10:00 PDT | Yountville, US

Roche's Pharma Day 2025Investors

September 22, 2025 at 09:00 BST | London, UK

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.